Physician profile
Taylor Lara
NPI 1063808806
$14,082.92
in general payments reported to CMS, 2019-2025
10 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,798 · 2021: $5,018 · 2022: $707 · 2023: $1,556 · 2024: $1,850 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,034 · Travel and Lodging: $1,142 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.42 |
| Travel and Lodging | $1,142.20 |
| Education | $382.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,080.30 | 2020-2022 | |
| Stryker Corporation | $2,379.86 | 2021-2025 | Insignia, Mako, Triathlon |
| Zimmer Biomet Holdings, INC. | $1,472.85 | 2023-2025 | Persona, Avenir, Arcos |
| Depuy Synthes Sales INC. | $1,012.84 | 2021-2024 | Actis, Na |
| Medtronic, INC. | $345.34 | 2021-2025 | Plasmablade(Tm), Aquamantys(Tm) |
| Medical Device Business Services, INC. | $228.31 | 2020-2025 | Attune |
| Omnilife Science, INC | $189.22 | 2021 | |
| Orthalign INC | $147.70 | 2023 | Orthalign Plus |
| Innovation Technologies INC | $113.50 | 2021 | |
| Medacta USA, INC. | $113.00 | 2022-2023 | Gmk Sphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Lara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.